Purity 99% Velpatasvir Powder Pharmaceutical Intermediate Velpatasvir Powder Material Velpatasvir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Velpatasvir
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Velpatasvir
• Name: Velpatasvir Powder
• Appearance: off-White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antivirus
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 1377049-84-7
• Mf: C49h54n8o8
• MW: 883.00200
• Einecs No.: 1592732-453-0
• Density: 1.314+-0.06 g/cm3(Predicted)
• Refractive Index: 1.643
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500 Kg/Month

Product Description

Purity 99% Velpatasvir Powder Pharmaceutical Intermediate Velpatasvir Powder Material Velpatasvir

 

Product Description

Product Details

Product Name	Velpatasvir
Appearance	Off-white powder
CAS No.	1377049-84-7
MF	C49H54N8O8
MW	883.00200

Velpatasvir is a Direct-Acting Antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV).Velpatasvir has a significantly higher barrier to resistance than the first generation NS5A inhibitors, such as Ledipasvir and Daclatasvir, making it a highly potent and reliable alternative for treatment of chronic Hepatitis C.Velpatasvir is currently only available within a fixed dose combination product as Epclusa with Sofosbuvir, another direct acting antiviral.

Application & Function

Verapatavir is an NS5A inhibitor in patients with hepatitis C virus (HCV) infection.
Velpatasvir is a universal NS5A inhibitor.   It can be used to treat adult patients infected with hepatitis C virus type 1~6, and can be used only for patients without cirrhosis or compensatory cirrhosis, or can be used with ribavirin to treat patients with decompensated cirrhosis.     Verapatavir is the second generation NS5A inhibitor, which has good antiviral activity in vitro against all genotypes of HCV and common NS5A mutations and drug resistance mutations.

Specification